Analysis of Gut Microbiota in Patients with Exacerbated Symptoms of Schizophrenia following Therapy with Amisulpride: A Pilot Study

Table 1

Changes of metabolic parameters and cytokines in amisulpride-treated patients. SCZ-AE: acute exacerbated schizophrenic patients; SCZ-T: SCZ-AE treated with amisulpride for 4 weeks; NA: not analyzed.

	SCZ-AE ()	SCZ-T ()	-test/chi-square test	value
Age (years)		—	NA	NA
Height (cm)		—	NA	NA
Body weight (kg)			-0.486	0.629
Systolic blood pressure (mmHg)			0.227	0.821
Diastolic blood pressure (mmHg)			2.929	0.0047
Heart rate (beats per minute)			3.730	0.00041
Fasting blood sugar (mmol/L)			0.997	0.322
Triglyceride (mmol/L)			-2.147	0.036
Total cholesterol (mmol/L)			-1.094	0.278
High-density lipoprotein cholesterol (mmol/L)			-1.316	0.193
Low-density lipoprotein cholesterol (mmol/L)			0.022	0.982
Interleukin-1β (pg/mL)			0.979	0.331
Interleukin-4 (pg/mL)			-1.990	0.050
Interleukin-6 (pg/mL)			2.039	0.046
Interferon-γ (pg/mL)			-1.243	0.218
Interleukin-10 (pg/mL)			-0.393	0.696
Tumor necrosis factor-α (pg/mL)			1.758	0.084